Cumulative organ damage at the end of follow up
| Damage | Controls | Cases |
|---|---|---|
| Results are shown as No (%). | ||
| *p<0.001; †p = 0.044; ‡p<0.001, renal and treatment means damage from both in the same patient; §cognitive impairment, seizures, cerebrovascular accidents, psychosis, cranial or peripheral neuropathies; ¶>3.5 g of protein/day or measured glomerular filtration rate <50% or end stage renal disease (regardless of dialysis or transplantation; **coronary artery disease, myocardial infarctions, peripheral thromboses, pericarditis; ††pulmonary hypertension, pulmonary emboli; ‡‡cataract, diabetes mellitus, muscle atrophy, amenorrhoea. | ||
| Cumulative SLICC* median (min–max) | 1 (0–12) | 2 (0–11) |
| Neuropsychiatric§ | 27/100 (27) | 13/50 (26) |
| Renal¶ | 7/100 (7) | 8/50 (16) |
| Cardiovascular** | 18/100 (18) | 16/50 (32) |
| Pulmonary†† | 5/100 (5) | 4/50 (8) |
| Treatment related‡‡ | 18/100 (18) | 14/50 (28) |
| Splenectomy† | 0/100 (0) | 2/50 (4) |
| Renal and treatment‡ | 0/100 (0) | 6/50 (12) |